COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,761 Articles (22,502 medRxiv, 8,259 bioRxiv)

Most recent first Previous |  Page 477: Articles 4761-4770  | Next

Nanoparticle-Conjugated TLR9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines
Ou, B. S., Picece, V. C. T. M., Baillet, J., Gale, E. C., Powell, A. E., Saouaf, O. M., Yan, J., Lopez Hernandez, H., Appel, E.
10.1101/2023.01.02.522505 — Posted: 2023-01-03
SARS-CoV-2 protein NSP2 enhances microRNA-mediated translational repression
Naeli, P., Zhang, X., Harris Snell, P., Chatterjee, S., Kamran, M., Ladak, R. J., Orr, N., Duchaine, T., Sonenberg, N., Jafarnejad, S. M.
10.1101/2023.01.01.522328 — Posted: 2023-01-03
Composition of nasopharyngeal microbiota in individuals with SARS-COV-2 infection across three COVID-19 waves in India
Bose, T., Wasimuddin, , Acharya, V., Pinna, N. K., Kaur, H., Ranjan, M., Jhandylala, S., Nagabandi, T., Varma, B., Tallapaka, K. B., Sowpati, D. T., Haque, M. M., Dutta, A., Siva, A. B., Mande, S. S.
10.1101/2023.01.02.522449 — Posted: 2023-01-03
A Gamma-adapted recombinant subunit vaccine induces broadly neutralizing antibodies against SARS-CoV-2 variants and protects mice from SARS-CoV-2 infection.
Coria, L. M., Rodriguez, J. M., Demaria, A., Bruno, L. A., Rios Medrano, M., Pueblas Castro, C., Castro, E. F., Del Priore, S. A., Hernando Insua, A. C., Kaufmann, I. G., Saposnik, L. M., Stone, W. B., Prado, L., Krum, V., Zurvarra, F. M., Sidabra, J. E., Drehe, I., Baque, J. A., Li Causi, M., De Nichilo, A. V., Payes, C. J., Auguste, A. J., Vega, J. C., Alvarez, D. E., Flo, J. M., Pasquevich, K. A., Cassataro, J.
10.1101/2023.01.03.522213 — Posted: 2023-01-03
Time Dependent Dihedral Angle Oscillations of the Spike Protein of SARS-CoV-2 Reveal Favored Frequencies of Dihedral Angle Rotations
Bastidas, O. H.
10.1101/2023.01.02.522466 — Posted: 2023-01-03
Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus Macaques
Shin, T.-H., Zhou, Y., Lee, B.-C., Hong, S. G., Andrew, S. F., Flynn, B. J., Gagne, M., Todd, J.-P. M., Moore, I. N., Cook, A., Lewis, M. G., Foulds, K. E., Seder, R. A., Doueck, D. C., Roederer, M., Dunbar, C. E.
10.1101/2023.01.01.522064 — Posted: 2023-01-03
Evaluation of Simple and Convenient Methods for SARS-CoV-2 Detection in Wastewater in high and Low Resource Settings
Liu, P., Guo, L., Cavallo, M., Cantrell, C., Hilton, S. P., Dunbar, J., Barbero, R., Barclay, R., Sablon, O., Wolfe, M. K., Lepene, B., Moe, C. L.
10.1101/2022.12.31.22284093 — Posted: 2023-01-03
Immunogenicity and safety of Biological Es CORBEVAX vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD or COVAXIN: A Prospective double-blind randomised phase III clinical study
Thuluva, S., Paradkar, V., Gunneri, S., Yerroju, V., Mogulla, R. R., Venkata Suneetha, P., Turaga, K., Binayke, A., Zaheer, A., Awasti, A., Virkar, R., Narang, M., Nanjappa, P., Mahantshetti, N., Garg, B., Mandal, R.
10.1101/2022.12.29.22284049 — Posted: 2023-01-03
Post-Exposure Prophylaxis with SA58 (anti-COVID-19 monoclonal antibody) Nasal Spray for the prevention of symptomatic Coronavirus Disease 2019 in healthy adult workers: A randomized, single-blind, placebo-controlled clinical study
Song, R., Zeng, G., Yu, J., Meng, X., Chen, X., Li, J., Xie, X., Lian, X., Zhang, Z., Cao, Y., Yin, W., Jin, R.
10.1101/2022.12.28.22283666 — Posted: 2023-01-03
Usability and performance of the MicroGEM Sal6830, an RT-PCR saliva-based point-of-care platform to detect SARS-CoV-2 in primary healthcare settings with non-laboratory trained operators.
Mills, V., Owen Tyson, T., Helton, R., Hill-Collins, P., Hubbard, S., Scott, A., Hickey, J., Root, B. E., O'Brien, R., Conte, J., Stanton, J.-A. L., Chapman, J. D.
10.1101/2023.01.01.22283267 — Posted: 2023-01-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).